Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, CXCR4 | 6 | 2018 | 69 | 2.140 |
Why?
|
| Prostatic Neoplasms | 9 | 2020 | 935 | 1.590 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2013 | 54 | 1.270 |
Why?
|
| Cannabinoids | 3 | 2023 | 56 | 1.110 |
Why?
|
| Neoplasms | 3 | 2023 | 1103 | 0.940 |
Why?
|
| Chemokine CXCL12 | 2 | 2018 | 29 | 0.940 |
Why?
|
| Hallucinogens | 1 | 2023 | 28 | 0.840 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2012 | 103 | 0.770 |
Why?
|
| Reactive Oxygen Species | 3 | 2013 | 461 | 0.770 |
Why?
|
| Cannabis | 1 | 2023 | 79 | 0.760 |
Why?
|
| Oxidative Stress | 5 | 2020 | 938 | 0.700 |
Why?
|
| Adaptation, Physiological | 1 | 2020 | 109 | 0.690 |
Why?
|
| Receptor, Cannabinoid, CB2 | 2 | 2018 | 32 | 0.690 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2018 | 2 | 0.630 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 269 | 0.630 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2018 | 30 | 0.620 |
Why?
|
| Heterocyclic Compounds | 1 | 2018 | 21 | 0.620 |
Why?
|
| Cell Nucleus | 3 | 2020 | 366 | 0.600 |
Why?
|
| Breast Neoplasms | 5 | 2016 | 1502 | 0.580 |
Why?
|
| Cell Line, Tumor | 11 | 2020 | 2231 | 0.560 |
Why?
|
| Protein Multimerization | 1 | 2016 | 103 | 0.500 |
Why?
|
| Karyopherins | 1 | 2013 | 6 | 0.450 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2013 | 18 | 0.440 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 2012 | 1 | 0.430 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 169 | 0.370 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 99 | 0.360 |
Why?
|
| Signal Transduction | 3 | 2014 | 1908 | 0.340 |
Why?
|
| Apoptosis | 7 | 2020 | 1398 | 0.340 |
Why?
|
| Humans | 19 | 2023 | 37093 | 0.320 |
Why?
|
| Cell Movement | 4 | 2018 | 571 | 0.320 |
Why?
|
| Brain Neoplasms | 1 | 2008 | 111 | 0.300 |
Why?
|
| Down-Regulation | 3 | 2018 | 435 | 0.290 |
Why?
|
| BRCA1 Protein | 1 | 2007 | 48 | 0.290 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2008 | 172 | 0.280 |
Why?
|
| Male | 11 | 2020 | 20025 | 0.270 |
Why?
|
| Phosphorylation | 4 | 2013 | 928 | 0.240 |
Why?
|
| Cell Survival | 5 | 2020 | 864 | 0.230 |
Why?
|
| Thiazoles | 2 | 2014 | 74 | 0.220 |
Why?
|
| Receptors, Cannabinoid | 1 | 2023 | 26 | 0.220 |
Why?
|
| Cell Proliferation | 4 | 2020 | 1198 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 807 | 0.220 |
Why?
|
| Endocannabinoids | 1 | 2023 | 39 | 0.210 |
Why?
|
| Blotting, Western | 3 | 2016 | 859 | 0.210 |
Why?
|
| Indoles | 2 | 2014 | 158 | 0.210 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2014 | 110 | 0.200 |
Why?
|
| Hydrogen Peroxide | 2 | 2013 | 190 | 0.190 |
Why?
|
| Culture Media, Serum-Free | 1 | 2020 | 45 | 0.190 |
Why?
|
| Minority Groups | 2 | 2022 | 596 | 0.170 |
Why?
|
| RNA, Small Interfering | 3 | 2013 | 409 | 0.170 |
Why?
|
| Protein Transport | 1 | 2020 | 302 | 0.170 |
Why?
|
| Peroxidase | 1 | 2019 | 49 | 0.170 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 67 | 0.170 |
Why?
|
| Cell Cycle | 1 | 2020 | 326 | 0.160 |
Why?
|
| Benzylamines | 1 | 2018 | 6 | 0.160 |
Why?
|
| Biomedical Research | 1 | 2022 | 400 | 0.160 |
Why?
|
| Phenotype | 1 | 2020 | 689 | 0.150 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 131 | 0.150 |
Why?
|
| NF-kappa B | 1 | 2020 | 339 | 0.150 |
Why?
|
| Cell Adhesion | 1 | 2018 | 212 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2008 | 161 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 502 | 0.120 |
Why?
|
| Cathepsin D | 1 | 2014 | 17 | 0.120 |
Why?
|
| Bone Neoplasms | 1 | 2013 | 45 | 0.110 |
Why?
|
| RNA Interference | 2 | 2012 | 243 | 0.110 |
Why?
|
| Arabidopsis | 1 | 2014 | 95 | 0.110 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 893 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 803 | 0.110 |
Why?
|
| Sesquiterpenes | 1 | 2012 | 32 | 0.110 |
Why?
|
| DNA Primers | 1 | 2013 | 286 | 0.110 |
Why?
|
| Animals | 4 | 2016 | 15081 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 173 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 84 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 98 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 190 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 623 | 0.100 |
Why?
|
| Female | 3 | 2018 | 20969 | 0.090 |
Why?
|
| Base Sequence | 1 | 2013 | 997 | 0.090 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 1180 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 208 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 252 | 0.090 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 1568 | 0.090 |
Why?
|
| Models, Biological | 1 | 2012 | 677 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1015 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2007 | 19 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2007 | 59 | 0.070 |
Why?
|
| Neuregulin-1 | 1 | 2007 | 23 | 0.070 |
Why?
|
| Receptor, erbB-2 | 1 | 2008 | 133 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 219 | 0.070 |
Why?
|
| Cytoplasm | 1 | 2007 | 143 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 172 | 0.070 |
Why?
|
| Hela Cells | 1 | 2007 | 366 | 0.070 |
Why?
|
| Mutation | 2 | 2007 | 1095 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2007 | 307 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 229 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2007 | 513 | 0.060 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2014 | 78 | 0.060 |
Why?
|
| Cell Line | 1 | 2007 | 1354 | 0.060 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 88 | 0.050 |
Why?
|
| Minority Health | 1 | 2022 | 88 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2013 | 251 | 0.050 |
Why?
|
| Research Personnel | 1 | 2022 | 155 | 0.050 |
Why?
|
| Trust | 1 | 2021 | 133 | 0.040 |
Why?
|
| Gluconeogenesis | 1 | 2019 | 10 | 0.040 |
Why?
|
| Research Design | 1 | 2021 | 313 | 0.040 |
Why?
|
| Transfection | 2 | 2012 | 523 | 0.040 |
Why?
|
| Metabolomics | 1 | 2019 | 81 | 0.040 |
Why?
|
| Proteomics | 1 | 2019 | 325 | 0.040 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2014 | 77 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2014 | 129 | 0.030 |
Why?
|
| Lysosomes | 1 | 2014 | 91 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 2721 | 0.030 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2013 | 62 | 0.030 |
Why?
|
| Caspase 7 | 1 | 2012 | 16 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2014 | 444 | 0.030 |
Why?
|
| Prostate | 1 | 2014 | 154 | 0.030 |
Why?
|
| United States | 1 | 2022 | 4223 | 0.030 |
Why?
|
| Autophagy | 1 | 2013 | 116 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2012 | 207 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 213 | 0.030 |
Why?
|
| Plant Extracts | 1 | 2014 | 286 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1039 | 0.020 |
Why?
|
| Antioxidants | 1 | 2012 | 416 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 1742 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2012 | 681 | 0.020 |
Why?
|
| Nuclear Envelope | 1 | 2007 | 9 | 0.020 |
Why?
|
| Lamin Type A | 1 | 2007 | 13 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 90 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2007 | 70 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2007 | 337 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2007 | 399 | 0.020 |
Why?
|
| Mice | 1 | 2007 | 5913 | 0.010 |
Why?
|